McKinsey, opioid plaintiffs spar over MDL venue


Consulting firm McKinsey & Co Inc on Thursday urged the Judicial Panel on Multidistrict Litigation to create a new MDL in the Southern District of New York consolidating lawsuits by local governments accusing it of contributing to the opioid epidemic through its work advising drug manufacturers.

Several plaintiffs' lawyers countered that claims against McKinsey should be consolidated in an existing MDL in the Northern District of Ohio where more than 3,000 lawsuits by local governments are already pending against drugmakers, distributors and pharmacies.

Plaintiffs have claimed that McKinsey, whose clients included Purdue Pharma, Mallinckrodt, Johnson & Johnson and Endo Pharmaceuticals, advised drugmakers to engage in misleading marketing about opioids' safety and addictiveness that led to an explosion of prescriptions.